A Review on Advancing Stem Cell Therapy and Tissue Engineering to Regenerate Damaged Tissues and Organs

Abstract

In the field of regenerative medicine, developing stem cell therapy and tissue engineering has become a game-changing strategy that holds promise for replacing and repairing damaged organs and tissues. Innovative biological interventions are required since traditional therapy approaches frequently fail to restore total structural and functional integrity. A dynamic platform for tissue regeneration is offered by stem cell treatment, which is distinguished by the special qualities of self-renewal and differentiation. Simultaneously, tissue engineering creates functioning tissue structures that resemble natural biological systems by combining cells, biomaterials, and bioactive chemicals. Recent advances have considerably improved the efficacy of these approaches by using induced pluripotent stem cells, biomimetic scaffolds, and advanced fabrication techniques including three-dimensional bioprinting. Furthermore, the use of gene editing technologies, such as CRISPR-Cas9, has created new opportunities for precision medicine and tailored regenerative therapies. Despite these advancements, other challenges remain, including ethical problems, immunological rejection, tumorigenicity, and regulatory constraints. This review seeks to provide a complete overview of current developments in stem cell therapy and tissue engineering, emphasizing their complementary roles in regenerative medicine. It also examines recent technology advances, clinical uses, and current problems, as well as future prospects for developing safe, effective, and scalable regenerative therapies. Keywords: 3D Bioprinting, Tissue Engineering, Regenerative Medicine, Growth Factors, Biomedical Engineering, Organ Transplantation, Stem Cell.